Syndax Pharmaceuticals, Inc. (SNDX)
24.64
+0.35
(+1.44%)
USD |
NASDAQ |
Apr 07, 16:00
25.50
+0.86
(+3.49%)
After-Hours: 20:00
Syndax Pharmaceuticals Shareholders Equity (Quarterly) : 64.63M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 636.37M |
| Vera Therapeutics, Inc. | 604.52M |
| Biogen, Inc. | 18.26B |
| Johnson & Johnson | 81.54B |
| Tango Therapeutics, Inc. | 346.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 529.71M |
| Total Liabilities (Quarterly) | 465.08M |
| Debt to Equity Ratio | 5.345 |
| Current Ratio | 4.396 |
| Net Debt Paydown Yield | -3.75% |